Anaplastic lymphoma kinase (ALK), epidermal growth factor receptor (EGFR), c-ros Repressor of Silencing 1 (ROS1) as crucial lung cancer gene targets have been unanimously recognized by today academic circles, and the era of targeted therapy has begun [24]. This evidence concerns the gene ROS1 and lung cancer.